Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

Management revised projected enrollment completion to the first half of 2026, citing "delays in the activation of the new ...

Guidance Raised -- 2025 revenue target increased to $80.5 million–$81.5 million, midpoint 38.7% growth; net income projected ...

Capital raised -- $17.1 million in new funding was secured, including a $13 million post-quarter investment from a leading ...

Pre-K Counts and Head Start providers across 32 counties have collectively taken on nearly $20 million in loans to mitigate ...

A long line formed Friday in Nashua as hundreds of Granite Staters waited to pick up food from a mobile food pantry.

VANCOUVER, BC / ACCESS Newswire / November 11, 2025 / (TSX:NANO)(OTCQB:NNOMF)(Frankfurt:LBMB) Business Operational Highlights Newly installed proprietary agitator in full-scale One-Pot™ reactor at ...

Q3 2025 Earnings Call November 13, 2025 10:00 AM ESTCompany ParticipantsManuel Zuniga Pflucker - President, CEO & ...

ESA said in a statement that the Artemis 4 Orion service module would begin its journey across the Atlantic Ocean "in a few ...

Q3 2025 Management View CEO Daniel O'Connell stated that "in the third quarter, we continued our track record of operational execution on 2 fronts: the steady progression of our Phase II ALTITUDE-AD ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q3 2025 Earnings Call Transcript November 12, 2025 Acumen Pharmaceuticals, Inc.

The mother of missing 9-year-old Melodee Buzzard has been charged with a felony unrelated to her daughter's disappearance, ...